
ALLOGENE THERAPEUTICS INC
ALLONASDAQ🏆 #2510 by market capEarnings Aug 12US Equity
$2.12▲ $0.00 (+0.00%)
Live1h▲ 1.2%
24h▲ 0.0%
7d▲ 8.7%
14d▲ 16.8%
30d▲ 9.6%
1y▲ 106.8%
🏦Market Cap
$732M
Small Cap
📈Revenue Growth (YoY)
-100.0%
Declining
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
57
Weak
📊
Analyst Ratings
Price
$2.12
Total
30
Raised
3
Lowered
4
Avg PT
$6.43
H / L
$9 / $4
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-04-16 |
JP Morgan | Upgraded | Underweight → Neutral | 2026-04-16 |
Jefferies | Reiterated | Buy | 2026-04-15 |
Baird | Reiterated | Outperform | 2026-04-14 |
Citizens | Reiterated | Market Outperform | 2026-04-14 |
Argus Research | Reiterated | Market Perform | 2026-04-14 |
Bernstein | Reiterated | Market Perform | 2026-04-14 |
Piper Sandler | Reiterated | Overweight | 2026-03-13 |
Canaccord Genuity | Reiterated | Buy | 2026-03-13 |
JMP Securities | Reiterated | Market Perform | 2025-08-04 |
Oppenheimer | Reiterated | Outperform | 2025-08-01 |
Citigroup | Reiterated | Buy | 2025-05-15 |
RBC Capital | Reiterated | Outperform | 2025-05-14 |
Truist Securities | Reiterated | Buy | 2025-05-14 |
Citizens Capital Markets | Upgraded | Market Perform → Market Outperform | 2025-03-14 |
Stifel | Reiterated | Hold | 2024-05-14 |
Guggenheim | Downgraded | Buy → Neutral | 2024-01-05 |
EF Hutton | Reiterated | Buy | 2023-08-03 |
Goldman Sachs | Reiterated | Buy | 2023-03-02 |
B of A Securities | Downgraded | Buy → Underperform | 2022-12-12 |
B. Riley Securities | Reiterated | Buy | 2022-09-22 |
Raymond James | Downgraded | Outperform → Market Perform | 2022-08-10 |
Roth Capital | Upgraded | Neutral → Buy | 2020-05-19 |
SunTrust Robinson Humphrey | Downgraded | Buy → Hold | 2020-05-14 |
Berenberg | Reiterated | Hold | 2020-02-24 |
BTIG | Reiterated | Buy | 2019-08-09 |
Stifel Nicolaus | Reiterated | Hold | 2019-05-23 |
PiperJaffray | Reiterated | Overweight | 2019-03-29 |
William Blair | Reiterated | Outperform | 2019-03-14 |
Cowen & Co. | Reiterated | Outperform | 2018-11-05 |
One row per institution, most recent rating